French stock alert

FRA

CLOSING UPDATE: Sartorius Stedim Biotech keeps sliding: down 13.8% in 5 days 26 July 2017 18:07 CEST

NEWS BITES - EUROPE

This is an end of day Alert, produced after today's French market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

Sartorius Stedim Biotech, France's 5th largest health care equipment & services company by market capitalisation, extended its slide on Wednesday, shedding an additional 2.0c (or 0.03%) to trade at EUR58.89. Trading volume was 1.3 times average at the end of the day. The shares have fallen EUR9.42 (or 13.8%) over the past five trading days vs. the CAC 40 Index which has fallen 0.5% in the same period.

Technical indicators complementing today's significant downtrend:

+ The negative 2.21 MACD (Moving Average Convergence Divergence) indicator suggests a bearish signal.

+ In the French market, the stock's relative price strength percentile is falling at 28 for 6 months, 28 for 3 months and 5 for 1 month.

+ The price plummeted 13.8% in the last week and 18.1% in the last month.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

+ Price/Sales of 5.2 [2.6]

Other Bearish Signals include:

+ Tobin's Q Ratio is 4.5. Compared with the rest of the market the stock is overvalued and ranks in the bottom 4% of stocks by value of Q Ratio.

Note

Sartorius Stedim Biotech today is at a discount of 19.0% to the 12-month high of EUR72.74 on 20 Jun, 2017. It is at a premium of 7.8% to the 12-month low of EUR54.61 on 31 Jan, 2017.

Bullish Signals:

In the last three months the stock has hit a new 52-week high six times, pointing to an uptrend.

Interest cover is less leveraged at 15.2 times.

Total Liabilities/EBITDA of 1.9 is comfortably below the Joseph Piotroski benchmark of <5.

Net profit margin has averaged 13% in the last 3 years. This is better than the sector average of 5.2% and suggests a high margin of safety.

As per the Du Pont analysis, Return on Equity is high at 20.9%. Also, this has improved from 18.9% last year.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

Return on Equity 20.9% [10.7%]

Return on Assets 13% [3.6%]

Return on Capital Employed 24.8% [7.9%]

TODAY'S ALERT

Afternoon Alert: Sartorius Stedim Biotech continues significant downtrend, decreases 0.6%

26 July 2017 14:04 CEST

Sartorius Stedim Biotech (FR:DIM) continued its significant downtrend and decreased 34.0c (or 0.6%) to trade at EUR58.57 today.

RECENT ALERTS

CLOSING UPDATE: Sartorius Stedim Biotech sank 4.3% on extraordinary volume

24 July 2017 18:03 CEST

Sartorius Stedim Biotech, France's 5th largest health care equipment & services company by market capitalisation, traded on heavy volume of 3.8 times average today while the price sank EUR2.64 (or 4.3%) to trade at EUR59.16. Compared with the CAC 40 Index which rose 1.9 points (or 0.04%) in the day, this represented a relative price change of -4.3%.

Afternoon Alert: Sartorius Stedim Biotech continues significant downtrend, sinks 5.7%

24 July 2017 14:04 CEST

Sartorius Stedim Biotech (FR:DIM) continued its significant downtrend and sank EUR3.50 (or 5.7%) to trade at EUR58.30 today.

Sartorius Stedim Biotech (FR:DIM; EPA:DIM; PA:DIM; FP:DIM)

ISIN: FR0013154002

PermID: 4295867687

Source: www.BuySellSignals.com